Skip to content

Functional outcome after radiotherapy for T2 glottic carcinoma

Functional outcome after radiotherapy for T2 glottic carcinoma - Functional outcomes after radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45759
Enrollment
30
Registered
2018-12-11
Start date
2019-01-08
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early glottic cancer vocal fold cancer

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients treated with radiotherapy for T2 glottic tumors, between 2008 and 2016 at the Leiden University Medical Center

Exclusion criteria

Exclusion criteria: sign of locoregional or distant metastasis previous radiation for head and neck tumor(s) inability to speak or read Dutch language

Design outcomes

Primary

MeasureTime frame
Voice quality Voice function Quality of life Swallowing function

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)